Session

Reflux disease (Posters)

RANGE OF PATHOLOGIES DIAGNOSED AMONG A SCREENING POPULATION OF PATIENTS WITH REFLUX DISEASE: RESULTS FROM THE CYTOSPONGE-BEST3 TRIAL
RANGE OF PATHOLOGIES DIAGNOSED AMONG A SCREENING POPULATION OF PATIENTS WITH REFLUX DISEASE: RESULTS FROM THE CYTOSPONGE-BEST3 TRIAL

IMPEDANCE-PH FINDINGS SUGGEST THAT GRADE B ESOPHAGITIS PROVIDES CONCLUSIVE DIAGNOSIS OF GERD: REAPPRAISAL OF LYON CONSENSUS CRITERIA FOR GERD DIAGNOSIS
IMPEDANCE-PH FINDINGS SUGGEST THAT GRADE B ESOPHAGITIS PROVIDES CONCLUSIVE DIAGNOSIS OF GERD: REAPPRAISAL OF LYON CONSENSUS CRITERIA FOR GERD DIAGNOSIS

THE EFFECT OF DEXRABEPRAZOLE ON INTRAGASTRIC AND INTRAESOPHAGEAL ACIDITY AND SYMPTOMS OF GASTROESOPHAGEAL REFLUX DISEASE
THE EFFECT OF DEXRABEPRAZOLE ON INTRAGASTRIC AND INTRAESOPHAGEAL ACIDITY AND SYMPTOMS OF GASTROESOPHAGEAL REFLUX DISEASE

THE UTILITY OF A MULTI-GENE METHYLATION PANEL TO RISK-STRATIFY PATIENTS WITH BARRETT’S ESOPHAGUS AFTER RADIOFREQUENCY ABLATION
THE UTILITY OF A MULTI-GENE METHYLATION PANEL TO RISK-STRATIFY PATIENTS WITH BARRETT’S ESOPHAGUS AFTER RADIOFREQUENCY ABLATION

MEAN NOCTURNAL BASELINE IMPEDANCE: A NOVEL METRIC WHICH MAY INCREASE THE DIAGNOSTIC VALUE OF 24 HOUR PH AND IMPEDANCE MONITORING
MEAN NOCTURNAL BASELINE IMPEDANCE: A NOVEL METRIC WHICH MAY INCREASE THE DIAGNOSTIC VALUE OF 24 HOUR PH AND IMPEDANCE MONITORING

ESOPHAGEAL MUCOSAL AND MOLECULAR DIFFERENCES BETWEEN FUNCTIONAL HEARTBURN AND HEALTHY ASYMPTOMATIC SUBJECTS
ESOPHAGEAL MUCOSAL AND MOLECULAR DIFFERENCES BETWEEN FUNCTIONAL HEARTBURN AND HEALTHY ASYMPTOMATIC SUBJECTS

ENDOSCOPIC FOLLOW-UP OF RADICALLY RESECTED SUBMUCOSAL ADENOCARCINOMA IN BARRETT’S ESOPHAGUS: EARLY RESULTS OF AN ONGOING PROSPECTIVE, INTERNATIONAL, MULTICENTER COHORT REGISTRY (PREFER TRIAL)
ENDOSCOPIC FOLLOW-UP OF RADICALLY RESECTED SUBMUCOSAL ADENOCARCINOMA IN BARRETT’S ESOPHAGUS: EARLY RESULTS OF AN ONGOING PROSPECTIVE, INTERNATIONAL, MULTICENTER COHORT REGISTRY (PREFER TRIAL)

THE CLINICAL UTILITY OF AN ENDOSCOPIC DIAGNOSIS OF HIATUS HERNIA
THE CLINICAL UTILITY OF AN ENDOSCOPIC DIAGNOSIS OF HIATUS HERNIA

FACTORS ASSOCIATED WITH HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH BARRETT ESOPHAGUS. A MULTI- CENTER CROSS SECTIONAL STUDY
FACTORS ASSOCIATED WITH HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH BARRETT ESOPHAGUS. A MULTI- CENTER CROSS SECTIONAL STUDY

FACTORS ASSOCIATED WITH HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH BARRETT ESOPHAGUS. A MULTI- CENTER CROSS SECTIONAL STUDY
FACTORS ASSOCIATED WITH HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH BARRETT ESOPHAGUS. A MULTI- CENTER CROSS SECTIONAL STUDY

Reflux disease (Posters)  et al.

THE CLINICAL UTILITY OF AN ENDOSCOPIC DIAGNOSIS OF HIATUS HERNIA
THE CLINICAL UTILITY OF AN ENDOSCOPIC DIAGNOSIS OF HIATUS HERNIA

Reflux disease (Posters)  et al.

ENDOSCOPIC FOLLOW-UP OF RADICALLY RESECTED SUBMUCOSAL ADENOCARCINOMA IN BARRETT’S ESOPHAGUS: EARLY RESULTS OF AN ONGOING PROSPECTIVE, INTERNATIONAL, MULTICENTER COHORT REGISTRY (PREFER TRIAL)
ENDOSCOPIC FOLLOW-UP OF RADICALLY RESECTED SUBMUCOSAL ADENOCARCINOMA IN BARRETT’S ESOPHAGUS: EARLY RESULTS OF AN ONGOING PROSPECTIVE, INTERNATIONAL, MULTICENTER COHORT REGISTRY (PREFER TRIAL)

Reflux disease (Posters)  et al.

ESOPHAGEAL MUCOSAL AND MOLECULAR DIFFERENCES BETWEEN FUNCTIONAL HEARTBURN AND HEALTHY ASYMPTOMATIC SUBJECTS
ESOPHAGEAL MUCOSAL AND MOLECULAR DIFFERENCES BETWEEN FUNCTIONAL HEARTBURN AND HEALTHY ASYMPTOMATIC SUBJECTS

Reflux disease (Posters)  et al.

MEAN NOCTURNAL BASELINE IMPEDANCE: A NOVEL METRIC WHICH MAY INCREASE THE DIAGNOSTIC VALUE OF 24 HOUR PH AND IMPEDANCE MONITORING
MEAN NOCTURNAL BASELINE IMPEDANCE: A NOVEL METRIC WHICH MAY INCREASE THE DIAGNOSTIC VALUE OF 24 HOUR PH AND IMPEDANCE MONITORING

Reflux disease (Posters)  et al.

THE UTILITY OF A MULTI-GENE METHYLATION PANEL TO RISK-STRATIFY PATIENTS WITH BARRETT’S ESOPHAGUS AFTER RADIOFREQUENCY ABLATION
THE UTILITY OF A MULTI-GENE METHYLATION PANEL TO RISK-STRATIFY PATIENTS WITH BARRETT’S ESOPHAGUS AFTER RADIOFREQUENCY ABLATION

Reflux disease (Posters)  et al.

THE EFFECT OF DEXRABEPRAZOLE ON INTRAGASTRIC AND INTRAESOPHAGEAL ACIDITY AND SYMPTOMS OF GASTROESOPHAGEAL REFLUX DISEASE
THE EFFECT OF DEXRABEPRAZOLE ON INTRAGASTRIC AND INTRAESOPHAGEAL ACIDITY AND SYMPTOMS OF GASTROESOPHAGEAL REFLUX DISEASE

Reflux disease (Posters)

IMPEDANCE-PH FINDINGS SUGGEST THAT GRADE B ESOPHAGITIS PROVIDES CONCLUSIVE DIAGNOSIS OF GERD: REAPPRAISAL OF LYON CONSENSUS CRITERIA FOR GERD DIAGNOSIS
IMPEDANCE-PH FINDINGS SUGGEST THAT GRADE B ESOPHAGITIS PROVIDES CONCLUSIVE DIAGNOSIS OF GERD: REAPPRAISAL OF LYON CONSENSUS CRITERIA FOR GERD DIAGNOSIS

Reflux disease (Posters)  et al.

RANGE OF PATHOLOGIES DIAGNOSED AMONG A SCREENING POPULATION OF PATIENTS WITH REFLUX DISEASE: RESULTS FROM THE CYTOSPONGE-BEST3 TRIAL
RANGE OF PATHOLOGIES DIAGNOSED AMONG A SCREENING POPULATION OF PATIENTS WITH REFLUX DISEASE: RESULTS FROM THE CYTOSPONGE-BEST3 TRIAL

Reflux disease (Posters)  et al.

Item 1 - 18 / 18
1